BelCosta Labs, a California third-party cannabis testing lab, announced the company is expanding its operations beyond California. BelCosta is combining businesses with independent testing labs US Cannalytics and Pinnacle CT Labs. USC currently services Florida, New Jersey, and Pennsylvania, and PCT services Maryland. All laboratories will be rebranded and operate as BelCosta Labs.
The merger combines over ten years of cannabis-specific, analytical testing expertise from five different state markets to create a national laboratory group.
“We are thrilled to be expanding our business out of state for the first time since starting BelCosta in 2017,” stated Myron Ronay, CEO of BelCosta Labs. “As one of the oldest testing labs in a mature market like California, we are eager to join forces with the U.S. Cannalytics team to provide cannabis producers across the country with high-quality testing services and insight.”
Founded in 2018, USC and PCT are a multi-state group of independent testing laboratories servicing medical and recreational cannabis and hemp/CBD markets. As one of the largest cannabis testing organizations on the East Coast with over seventy-five years of combined management experience across medical, pharmaceutical, and other professional fields, USC and PCT have emerged as leaders in the East Coast markets.
"We are excited to join BelCosta Labs and to work collaboratively with a great team to advance the cannabis testing industry," stated Karrissa Miller, director of client services for USC and PCT. “USC and PCT pride ourselves on our highly skilled team's vast experience and knowledge; joining BelCosta enhances our ability to exceed minimum regulatory and quality requirements for our current and future customer base."
Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.
Photo by Louis Reed on Unsplash
Related News
Is Cannabis Education A Solution To Prevent Testing Labs From Focusing On THC Potency?
Cannabis Lab Experts Discuss Some Of Pot's Most Pressing Areas Of Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.